Zealand Pharma A/S

Stocks

ZEAL

DK0060257814

Real-time Estimate Cboe Europe Other stock markets 09:57:39 2026-07-10 am EDT			5-day change	1st Jan Change
286.00 ^DKK	-0.59%		-5.33%	-38.70%

Jul. 07	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
Jun. 23	U.S. Futures, European Stocks Down Slightly	DJ

Transcript : Zealand Pharma A/S Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 01

Published on 06/09/2026 at 02:35 pm EDT - Modified on 06/09/2026 at 04:51 pm EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Rajan Sharma (Analysts)

Good afternoon, everyone. Thanks for joining us. My name is Rajan Sharma, European pharma and biotech analyst here at Goldman Sachs. Very pleased to have

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Zealand Pharma A/S

Jul. 07	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
Jun. 23	U.S. Futures, European Stocks Down Slightly	DJ
Jun. 18	Berenberg Lowers Zealand Pharma to Hold Amid 'Limited' Near-term Catalysts; Price Target Down	MT
Jun. 17	Auto1 Shifts into High Gear, BMW Downshifts
Jun. 17	U.S. Futures Edge Up, European Stocks Mixed	DJ
Jun. 17	Berenberg Downgrades Zealand Pharma to Hold from Buy, Sets Price Target at DKK300: BN	FW
Jun. 16	UBS Cuts Price Target on Zealand Pharma
Jun. 16	UBS Cuts Zealand Pharma PT, Affirms Buy Rating	MT
Jun. 16	UBS lowers price target for Zealand Pharma to DKK 540 (730), reiterates buy rating	FW
Jun. 12	After Euphoria, a Traffic Jam on the Multi-Billion Dollar Kilo-Highway
Jun. 12	After the Euphoria, a Traffic Jam on the Multi-Billion Dollar Highway
Jun. 11	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
Jun. 11	Wolfe Downgrades Zealand Pharma Following Weak Tolerability Data for Obesity Drug	FW
Jun. 10	Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon	RE
Jun. 10	DNB Carnegie trims Zealand Pharma price target to DKK 425 (440), reiterates Buy	FW